The Vanguard Group 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 2,974,638 5.730% |
328,272 (+12.40%) |
Filing |
| 2023-10-10 11:07 am Sale |
2023-09-29 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 2,646,366 5.110% |
-2,759,908 (-51.05%) |
Filing |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 5,406,274 10.840% |
53,322 (+1.00%) |
Filing |
| 2022-03-09 08:44 am Sale |
2022-02-28 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 5,352,952 10.600% |
-9,079 (-0.17%) |
Filing |
| 2022-02-10 08:11 am Sale |
2021-12-31 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 5,362,031 9.970% |
-54,813 (-1.01%) |
Filing |
| 2021-12-09 1:54 pm Purchase |
2021-11-30 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 5,416,844 10.070% |
626,271 (+13.07%) |
Filing |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 4,790,573 9.040% |
123,327 (+2.64%) |
Filing |